Cut redundant medicines in elderly cancer patients

摘要

Older patients with terminal cancers are frequently taking several drugs for co-morbidities, many of which could be stopped to reduce adverse reactions and simplify their treatment, according to a US study presented at the American Society of Clinical Oncology annual meeting held in Chicago last weekend.